Outcomes and Safety

Therapy participants have adverse events reviewed during each treatment session, while waitlist controls are contacted at Week 10 and Week 20. Adverse events may include worsening prior symptoms, recurrence of previous symptoms, diagnosis of a new medical condition, new symptoms or injuries.